Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches
- PMID: 14699367
- DOI: 10.1016/s0190-9622(03)00786-2
Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches
Abstract
Because the etiopathogenesis of depigmentation in vitiligo is still obscure, the source of pigmentation in the repigmentating lesion and its stability is also not fully known. Several authors have shown on histopathology and electron microscopy predominantly a perifollicular spread of pigment. The aim of this study was to clinically assess the types of repigmentation patterns obtained with different treatment modalities and their correlation with speed and stability of repigmentation. A total of 125 patients with vitiligo on treatment with psoralens (topical and systemic psoralen-UVA [PUVA]), steroids (both topical and systemic), and topical calcipotriol, alone or in combination were enrolled. Representative lesions of vitiligo excluding mucosal sites were selected in each patient and photographed at baseline. Repigmentation was assessed and labeled as marginal, perifollicular, diffuse, or combined. The preselected patches were evaluated at 3 months to assess the speed of repigmentation. Retention of pigment (stability) was noted at 6 months, after the stoppage of active treatment. Of the 352 vitiligo patches selected, 194 (55%) showed predominant perifollicular repigmentation, of which a majority (127; 65.5%) were on systemic PUVA and 35 (18%) were on topical PUVA. Diffuse pigmentation was observed in 98 patches (27.8%) of which 66 (67.3%) were on topical steroids. Marginal repigmentation was seen in 15, of which the majority (80%) were on systemic PUVA and topical calcipotriol. Of the 28 total lesions showing marked repigmentation at 3 months, 22 lesions pigmented in a diffuse manner, 2 in a perifollicular pattern, and 4 showed a combined type of repigmentation. On follow-up, marginal repigmentation was the most stable (93.3%), followed by perifollicular (91.7%) and combined type (84.4%). Diffuse repigmentation was the least stable (78.5%). Psoralens predominantly exhibit a perifollicular pattern of repigmentation and steroids (topical/systemic), a diffuse type. The speed of repigmentation is much faster when initial repigmentation is of the diffuse type as compared with follicular repigmentation. The marginal and perifollicular repigmentation is more stable than the diffuse type of repigmentation.
Similar articles
-
Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.Br J Dermatol. 2001 Sep;145(3):472-5. doi: 10.1046/j.1365-2133.2001.04286.x. Br J Dermatol. 2001. PMID: 11531839 Clinical Trial.
-
Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.J Am Acad Dermatol. 2001 Apr;44(4):634-7. doi: 10.1067/mjd.2001.112357. J Am Acad Dermatol. 2001. PMID: 11260538 Clinical Trial.
-
Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.Br J Dermatol. 2001 Sep;145(3):476-9. doi: 10.1046/j.1365-2133.2001.04381.x. Br J Dermatol. 2001. PMID: 11531840 Clinical Trial.
-
Update on skin repigmentation therapies in vitiligo.Pigment Cell Melanoma Res. 2009 Feb;22(1):42-65. doi: 10.1111/j.1755-148X.2008.00528.x. Epub 2008 Nov 27. Pigment Cell Melanoma Res. 2009. PMID: 19040503 Review.
-
Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.Photodermatol Photoimmunol Photomed. 2017 Jan;33(1):22-31. doi: 10.1111/phpp.12277. Epub 2016 Nov 23. Photodermatol Photoimmunol Photomed. 2017. PMID: 27696531 Review.
Cited by
-
Possible mechanisms by which topical 5-Fluorouracil and dermabrasion could induce pigment spread in vitiligo skin: an experimental study.ISRN Dermatol. 2013 Apr 9;2013:852497. doi: 10.1155/2013/852497. Print 2013. ISRN Dermatol. 2013. PMID: 23691347 Free PMC article.
-
Melanocyte stem cells as potential therapeutics in skin disorders.Expert Opin Biol Ther. 2014 Nov;14(11):1569-79. doi: 10.1517/14712598.2014.935331. Epub 2014 Aug 8. Expert Opin Biol Ther. 2014. PMID: 25104310 Free PMC article. Review.
-
Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.Med Res Rev. 2017 Jul;37(4):907-935. doi: 10.1002/med.21426. Epub 2016 Dec 28. Med Res Rev. 2017. PMID: 28029168 Free PMC article. Review.
-
Use of Dermatoscope to Monitor the Repigmentation of Various Vitiligo Surgical Procedures.J Cutan Aesthet Surg. 2016 Oct-Dec;9(4):286-287. doi: 10.4103/0974-2077.197090. J Cutan Aesthet Surg. 2016. PMID: 28163468 Free PMC article. No abstract available.
-
Melanocyte stem cells in skin diseases and their potential in cell-based therapy.Histol Histopathol. 2022 Oct;37(10):937-953. doi: 10.14670/HH-18-470. Epub 2022 May 13. Histol Histopathol. 2022. PMID: 35553404 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical